Latest Breaking News On - Hc wainwright equity research - Page 1 : comparemela.com

NANTES, France (BUSINESS WIRE) Regulatory News:OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announced today that the leadership team will attend several investor conferences in September and October 2022.Conference details:- H.C. Wainwright 24th Annual Global Investment ConferenceFormat: Fireside cha.

New yorkUnited statesFrance generalUniversity hospitalNoord hollandSean leeAlexis vandierThomas guillotNantes university hospitalVeloxis pharmaceuticals incBoehringer ingelheimHc wainwright equity researchRegulatory newsAnnual global investment conferenceEquity research associateChief executive officer